pharmaphorum

FEBRUARY 12, 2021

Along with the $350 million upfront fee Sandoz is also pledging $150 million tied to sales performance in the deal, which excludes some rights to the drug in some markets including the US, China, Germany and Australia.

110

110

pharmaphorum

JUNE 17, 2021

While the heroic abilities of the NHS have been on display throughout the COVID-19 pandemic, the last year has also exposed the longstanding limitations and frailties of our underfunded healthcare system, says Maya Ward. The digitalisation of the healthcare system should provide much needed efficiency as well as support better outcomes.

114

114

Pharmaceutical Technology

DECEMBER 5, 2022

Women’s healthcare company TherapeuticsMD has sign ed agreements for licensing its products to the Mayne Pharma affiliate in the US. Under the agreement, Mayne will make an upfront payment of $140m in cash to TherapeuticsMD for obtaining a licence and some other assets at closing.

52

52

Pharmaceutical Technology

NOVEMBER 15, 2022

Jnana Therapeutics co-founder and CEO Joanne Kotz said: “We are excited to partner with Roche, one of the largest healthcare companies and a strong collaborator, for a second time. According to the partnership, Roche will make $50m in upfront payments to Jnana.

Immunization 52

Immunization 52

Pharmaceutical Technology

JULY 14, 2022

Innoviva has signed an agreement for the sale of its 15% economic stake in Theravance Respiratory Company (TRC) to Royalty Pharma for nearly $282m in upfront cash payments and a potential contingent sales-based milestone payment of $50m. TRC receives royalties generating from sales of TRELEGY ELLIPTA (the combination FF/UMEC/VI).

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

FEBRUARY 3, 2022

India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum.

Compounding 118

Compounding Insurance 118

pharmaphorum

MARCH 31, 2022

Fresenius Kabi is buying 55% of mAbxience – a subsidiary of Spanish drugmaker Insud Pharma – for €495 million (around $550 million) upfront and undisclosed milestone payments, bolting on two commercially-available biosimilars (rituximab and bevacizumab) and a pipeline of several others in development.

Vaccines 52

Vaccines 52

pharmaphorum

NOVEMBER 2, 2022

Australia’s CSL is the latest vaccines company to buy into the mRNA category, tapping US biotech Arcturus Therapeutics for a wide-ranging alliance targeting COVID-19, influenza and other respiratory pathogens, including those that may cause future pandemics. For example, Sanofi paid $3.2

Vaccines 52

Vaccines Immunization 52

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 billion, with upfront consideration of $1.25 on 6 th January.

FDA 93

FDA 93

pharmaphorum

DECEMBER 16, 2022

CSL paid $450 million upfront to the gene therapy from its developer uniQure in 2020, in a deal that could end up being worth more than $2 billion, factoring in potential milestone payments. The two companies are also planning to sell etranacogene dezaparvovec under the Hemgenix brand in the EU, assuming its gets approval.

FDA 122

FDA 122

The Checkup by Singlecare

DECEMBER 28, 2023

Your healthcare provider will likely ask you questions about your lifestyle, diet, and medical history as well as your past experience with weight loss programs. There are also various online telehealth sources that prescribe semaglutide, the active ingredient in Ozempic, for an upfront monthly fee. mg weekly.”

Insurance 104

Insurance Insurance Coverage FDA Documentation 104

pharmaphorum

JANUARY 11, 2022

Bristol-Myers Squibb chief executive Giovanni Caforio has promised to invest in the company’s pipeline at the virtual JP Morgan Healthcare Conference, and demonstrated that commitment by licensing up to four cancer cell therapy candidates from Century Therapeutics.

93

93

pharmaphorum

APRIL 27, 2022

Trust in life science companies has fluctuated since the start of the pandemic. Especially, women tend to have more distrust in pharmaceutical companies. partaking in vaccination and preventive medicine), highlighting the importance of trust in pharma and healthcare. Transparency: the key to increasing trust?

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies 93

pharmaphorum

APRIL 25, 2022

The partnership marks one of the biggest deals between a pharma organisation and a VR company in history and highlights the increasing intersection between immersive technology and healthcare. In 2021, the two companies signed a milestone agreement, which includes a multi-product, multi-DTx deal for mental health.

FDA 103

FDA 103

Pharmaceutical Technology

APRIL 19, 2023

Following Bayer’s takeover of Schering Healthcare in 2006, where it inherited the oral contraceptive Yasmin (ethinyl estradiol + drospirenone) and the intrauterine device Mirena (levonorgestrel-releasing system), the German drugmaker has become one of the world’s leading pharmaceutical specialists in women’s health.

52

52

pharmaphorum

OCTOBER 19, 2022

Companies today need to increase the quantity of content, reuse dynamic content across multiple channels, and understand how to distribute relevant content to their customers in the right place at the right time. We don’t have newer people to manage that within companies, so modular content has to.

Communication 89

Communication Pharmaceutical Companies Pharmaceutical Companies 89

pharmaphorum

OCTOBER 28, 2022

They drive development from a top-down approach, informed by and subject to the biases, blind spots, and ingrained habits of the company. Co-design a Target Product Profile (TPP) with key audiences – TPP testing is typically done with a profile developed by the company that is then tested with audience members to get their feedback.

Documentation 99

Documentation 99

pharmaphorum

OCTOBER 25, 2022

If completed, the acquisition – which has been termed a “low ball bid” by some – of AGTC will become Syncona’s third company focused on retinal gene therapy (after Nightstar and Gyroscope , acquired by Biogen and Novartis, respectively). The company has entered into strategic collaborations with Bionic Sight, Inc. – per share).

FDA 52

FDA 52

pharmaphorum

JANUARY 31, 2022

Creating personalised, compliant content is becoming increasingly important for life science companies as HCPs demand more from their digital content. Pharma companies created 3.5 Armed with this combination of an upfront strategy and purpose-built software, marketers can instead focus on delivering high-value content to meet demands.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Digital Pharmacist

SEPTEMBER 12, 2022

Upfront pricing. Most pharmacies will perform thes e functions, but we did see with Mark Cuban Cost Plus Drug Company, that they will not be contacting pharmacies or physicians’ offices – it is the patient’s responsibility to provide the prescriptions to them. Easy refills. No more waiting in pharmacy lines.”

Independent Pharmacies 99

Independent Pharmacies Packaging Insurance 99

pharmaphorum

JANUARY 11, 2023

The company’s chief executive Jean-Jacques Bienaimé told the JP Morgan healthcare conference this week that it expects to sign several more contracts with German insurers in the coming weeks, and has started reimbursement negotiations with the authorities in France and Italy.

Insurance 52

Insurance 52

pharmaphorum

OCTOBER 20, 2021

The renaissance of Biogen and Sage Therapeutics antidepressant zuranolone continues, with the companies indicating they now plan to start a rolling submission for the drug early next year.

FDA 52

FDA Packaging 52

pharmaphorum

OCTOBER 19, 2021

For Lilly, it also raises the prospect of expanded use for sintilimab in NSCLC that will help justify the $1 billion-plus licensing deal – including $200 million upfront – that it signed with Innovent last year. The post Good news for Lilly as sintilimab hits the spot in lung cancer again appeared first on.

Chemotherapy 52

Chemotherapy Hospitals 52

pharmaphorum

JUNE 22, 2021

This morning the drugmaker’s majority owned HIV unit ViiV Healthcare announced a partnership with drug delivery specialist Halozyme to develop four HIV therapies that could be dosed as infrequently as once every six months or more.

FDA 52

FDA Hospitals 52

pharmaphorum

DECEMBER 18, 2022

However, most models are based on an old-fashioned and expensive call centre-based approach that fails to meet the needs of patients and healthcare providers (HCPs) as consumers. Yet, the healthcare experience is antiquated. entertainment or consumer apps), before it is production-worthy for mission-critical healthcare applications.

Specialty Pharmacies 94

Specialty Pharmacies 94

pharmaphorum

JANUARY 21, 2021

Between them, Royal Philips and Thermo Fisher have been driving a mini M&A spree in the medical technology sector, snapping up three companies in the last few weeks. Thermo is paying $450 million upfront for Mesa with another $100 million on offer if the device meets certain development and sales targets.

Medical Records 52

Medical Records Patient Care Hospitals FDA 52

pharmaphorum

SEPTEMBER 5, 2022

Given that enormous burden on healthcare systems, some analysts have previously predicted that sales of D-PLEX 100 could reach $2 billion a year. Last month, Advanz Pharma licensed European rights to D-PLEX 100 for the prevention of SSIs in abdominal and cardiac surgeries in a deal valued at up to $110 million for the Israeli company.

Hospitals 78

Hospitals FDA 78

pharmaphorum

NOVEMBER 23, 2022

uniQure and CSL have become the first pharma companies to get regulatory approval for a gene therapy for haemophilia B anywhere in the world, after the FDA cleared their Hemgenix therapy for adults with the bleeding disorder in the US. That is well above the $2.9

FDA 59

FDA 59

Pharmaceutical Technology

JULY 14, 2022

Without a guaranteed return on investment (ROI), it is understandable why any for-profit company would show reluctance. Such movements have enabled pharmaceutical companies to increase their focus on rare diseases, and the number of orphan drug launches is steadily increasing. Efforts have been made to change this.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

pharmaphorum

MAY 5, 2022

The company has secured $100 million upfront – with the remaining $160 million due if the erosive oesophagitis approval comes through – from Sagard Healthcare Partners, NovaQuest Capital Management and Hercules Capital.

FDA 52

FDA 52

pharmaphorum

JULY 26, 2022

NewAmsterdam Pharma has charted out a route to a Nasdaq listing by merging with black cheque company Frazier Lifesciences in a deal that will provide additional cash for its main drug candidate – oral CETP inhibitor obicetrapib. Remember CETP?

52

52

Aureus Medical Group

NOVEMBER 7, 2022

Be upfront and transparent. Different companies will offer different compensation, benefits packages, and placements, so of course you’d want to find the best option that checks your most important boxes. in a travel healthcare recruiter and how to navigate the pros and cons of healthcare traveling.

Communication 52

Communication Packaging 52

pharmaphorum

MAY 18, 2021

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. He takes us through the challenges of a successful launch and explains what pre-commercial companies need to focus on to hit their goals. Agile, scalable and data-driven.

52

52

pharmaphorum

APRIL 7, 2021

“It would be so good for Europe to have an independent biotech company”. While the Darzalex revenues are due to fall this year because of Janssen’s interpretation of the agreement between the two companies, there are also other revenue streams. Genmab last year received nearly 4.4

Chemotherapy 71

Chemotherapy Hospitals Vaccines 71

The Checkup by Singlecare

MARCH 30, 2023

Keep in mind that some health insurance companies do not cover vitamin D testing, a blood test to confirm low levels of vitamin D. Though the 90-day supply may cost more upfront, it will save money in the long run. Copay costs should be low. How much does vitamin D cost without insurance?

Insurance 52

Insurance Insurance Coverage Health Insurance Companies Immunization 52

The Checkup by Singlecare

MAY 1, 2024

The insurance company will provide you with precise information. Lease programs let you enjoy the latest tech without a hefty upfront payment. Discount programs Third-party companies offer discount programs that make hearing aids more affordable, too. The company advertises name-brand equipment at up to 40% off retail costs.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Insurance Coverage Communication 52

DiversifyRx

MAY 9, 2024

Below are just a few extra benefits of adding vaccine services to your pharmacy: Helps protect your community and prevent disease Vaccines are a cornerstone of preventive healthcare. You can also work with companies like Prescribe Wellness, which will provide signed protocols for a small fee. Tell patients what to expect.

Vaccines 52

Vaccines Health and Personal Care Stores Immunization Independent Pharmacies 52